FDA Adverse Event Malfunction Summary report: N

OPTIPAC 60 REFOBACIN BN CMT R ENT R

MDR report key: 8256083 · Received January 17, 2019

Report

Report Number
3006946279-2019-00050
Event Type
Malfunction
Date Received
January 17, 2019
Date of Event
December 19, 2018
Report Date
July 18, 2019
Manufacturer
BIOMET FRANCE S.A.R.L.
Product Code
MBB
PMA / PMN Number
K150850
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
BE
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

(B)(4). THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. THE RETURNED ITEM HAS BEEN INSPECTED. THE EVALUATION SHOWED THAT THE TWO POUCHES WERE PUNCTURED BY CANNULA AND PARTIALLY EMPTY. THE VACUUM TEST WAS PERFORMED AND THE SYSTEM WAS NOT TIGHT. THE DOCUMENTARY REVIEW SHOWED THAT PRODUCTS WERE MANUFACTURED ACCORDING TO THE PRE-DEFINED SPECIFICATIONS OF BIOMET FRANCE. WITH THE AVAILABLE INFORMATION, THE EXACT ROOT CAUSE OF THE EVENT COULD NOT BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Additional Manufacturer Narrative · 0

(B)(4). THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.

Additional Manufacturer Narrative · 0

(B)(4) THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. AN INVESTIGATION HAS BEEN PERFORMED, CONSISTING OF A DOCUMENTARY REVIEW AND A PRODUCT ANALYSIS. THE DOCUMENTARY REVIEW SHOWED THAT PRODUCTS WERE MANUFACTURED ACCORDING TO THE PRE-DEFINED SPECIFICATIONS OF BIOMET FRANCE. THE RETURNED ITEM HAS BEEN INSPECTED AND THE VACCUM WAS NOT TIGHT BUT NO NON CONFORMITY WAS DETECTED ON THE PRODUCT. THE ROOT CAUSE COULD NOT BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

IT HAS BEEN REPORTED THAT THE NURSE TRIED MIXING THE CEMENT WHEN THE LIQUID DID NOT WANT TO MOVE INTO THE SYRINGE.

Description of Event or Problem · 0

IT HAS BEEN REPORTED THAT THE NURSE TRIED MIXING THE CEMENT WHEN THE LIQUID DID NOT WANT TO MOVE INTO THE SYRINGE.

Description of Event or Problem · 0

IT HAS BEEN REPORTED THAT THE NURSE TRIED MIXING THE CEMENT WHEN THE LIQUID DID NOT WANT TO MOVE INTO THE SYRINGE.

Additional Manufacturer Narrative · 1

(B)(4). UNIQUE IDENTIFIER (UDI) # :(B)(4). REPORT SOURCE, FOREIGN - EVENT OCCURRED IN (B)(6). THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.

Description of Event or Problem · 1

IT HAS BEEN REPORTED THAT THE LIQUID IS NOT ENTERING THE SYRINGE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
49429 OPTIPAC 60 REFOBACIN BN CMT R ENT R BONE CEMENT, ANTIBIOTIC MBB BIOMET FRANCE S.A.R.L. A715A08935

Patients

Seq Age Sex Outcome Treatment
1